Silencing of osteopontin promotes the radiosensitivity of breast cancer cells by reducing the expression of hypoxia inducible factor 1 and vascular endothelial growth factor

Chinese Medical Journal

Volumn 125, Issue 2, 2012, Pages 293-299

  Yang, Li ^a   Zhao, Wei ^a   Zuo, Wen Shu ^a   Wei, Ling ^a   Song, Xian Rang ^a   Wang, Xing Wu ^a   Zheng, Gang ^a   Zheng, Mei Zhu ^a  

^a SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Breast cancer; Osteopontin; Radiosensitivity; Small interfering RNA

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; MESSENGER RNA; OSTEOPONTIN; SMALL INTERFERING RNA; VASCULOTROPIN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER RADIOTHERAPY; CELL AGING; CELL HYPOXIA; CELL INVASION; CELL PROLIFERATION; CELL SURVIVAL; CLONOGENESIS; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR STABILITY; RADIATION DOSE; RADIOSENSITIVITY; RECOMBINANT PLASMID; UPREGULATION; WILD TYPE;

BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; OSTEOPONTIN; RADIATION TOLERANCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84862947384     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.02.024     Document Type: Article

References (21)

1. Li ZS, Yao L, Liu YQ, Ouyang T, Li JF, Wang TF, et al. Breast cancer subtypes and survival in Chinese women with operable primary breast cancer. Chin J Cancer Res 2011; 23: 134-139
2. Wang N, Zhu WX, Xing XM, Yang L, Li PP, You WC. Time trends of cancer incidence in urban Beijing, 1998-2007. Chin J Cancer Res 2011; 23: 15-20.
3. Zhang R, Wang J, Ma S, Huang Z, Zhang G. Requirement of Osteopontin in the migration and protection against Taxol-induced apoptosis via the ATX-LPA axis in SGC7901 cells. BMC Cell Biol 2011; 12: 11.
4. Wong TS, Kwong DL, Sham J, Wei WI, Kwong YL, Yuen AP. Elevation of plasma osteopontin level in patients with undifferentiated nasopharyngeal carcinoma. Eur J Surg Oncol 2005; 31: 555-558.
5. Mi Z, Bhattacharya SD, Kim VM, Guo H, Talbot LJ, Kuo PC. Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis. Carcinogenesis 2011; 32: 477-487.
6. Ling LJ, Wang S, Liu XA, Shen EC, Ding Q, Lu C, et al. A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone. Chin Med J 2008; 121: 1980-1986.
7. Moulder JE, Martin DF. Hypoxic fraction determinations with the BA1112 rat sarcoma: variation within and among assay techniques. Radiat Res 1984; 98: 536-548.
8. Zips D, Boke S, Kroeber T, Meinzer A, Brüchner K, Thames HD, et al. Prognostic value of radiobiological hypoxia during fractionated irradiation for local tumor control. Strahlenther Onkol 2011; 187: 306-310.
9. Bouchat V, Nuttens VE, Michiels C, Masereel B, Feron O, Gallez B, et al. Radioimmunotherapy with radioactive nanoparticles: biological doses and treatment efficiency for vascularized tumors with or without a central hypoxic area. Med Phys 2010; 37: 1826-1839.
10. Avanzo M, Stancanello J, Franchin G, Sartor G, Jena R, Drigo A, et al. Correlation of a hypoxia based tumor control model with observed local control rates in nasopharyngeal carcinoma treated with chemoradiotherapy. Med Phys 2010; 37: 1533-1544.
11. Bache M, Reddemann R, Said HM, Holzhausen HJ, Taubert H, Becker A, et al. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels. Int J Radiat Oncol Biol Phys 2006; 66: 1481-1487.
12. Sorensen BS, Hao J, Overgaard J, Vorum H, Honoré B, Alsner J, et al. Influence of oxygen concentration and pH on expression of hypoxia induced genes. Radiother Oncol 2005; 76: 187-193.
13. Said HM, Hagemann C, Staab A, Stojic J, Kühnel S, Vince GH, et al. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo. Radiother Oncol 2007; 83: 398-405.
14. Liu SJ, Hu GF, Liu YJ, Liu SG, Gao H, Zhang CS, et al. Effect of human osteopontin on proliferation, transmigration and expression of MMP-2 and MMP-9 in osteosarcoma cells. Chin Med J 2004; 117: 235-240.
15. Grimm A, Dimmler A, Stange S, Labanaris A, Sauer R, Grabenbauer G, et al. Expression of HIF-1 alpha in irradiated tissue is altered by topical negative-pressure therapy. Strahlenther Onkol 2007; 183: 144-149.
16. Dewhirst MW, Cao Y, Li CY, Moeller B. Exploring the role of HIF-1 in early angiogenesis and response to radiotherapy. Radiother Oncol 2007; 83: 249-255.
17. Solberg TD, Nearman J, Mullins J, Li S, Baranowska-Kortylewicz J. Correlation between tumor growth delay and expression of cancer and host VEGF, VEGFR2, and osteopontin in response to radiotherapy. Int J Radiat Oncol Biol Phys 2008; 72: 918-926.
18. Bellahcene A, Bachelier R, Detry C, Lidereau R, Clézardin P, Castronovo V. Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells. Breast Cancer Res Treat 2007; 101: 135-148.
19. Bramwell VH, Doig GS, Tuck AB, Wilson SM, Tonkin KS, Tomiak A, et al. Serial plasma osteopontin levels have prognostic value in metastatic breast cancer. Clin Cancer Res 2006; 12: 3337-3343.
20. Lukacova S, Khalil AA, Overgaard J, Alsner J, Horsman MR. Relationship between radiobiological hypoxia in a C3H mouse mammary carcinoma and osteopontin levels in mouse serum. Int J Radiat Biol 2005; 81: 937-944.
21. Hahnel A, Wichmann H, Kappler M, Kotzsch M, Vordermark D, Taubert H, et al. Effects of osteopontin inhibition on radiosensitivity of MDA-MB-231 breast cancer cells. Radiat Oncol 2010: 5: 82.